Virtual Reality Mindfulness Intervention for Supporting People With HIV and Substance Use
| Registry | NCT07088289 |
|---|---|
| Status | Not yet recruiting |
| Phase | Not applicable |
| Study type | Interventional; na, single group, masking: none, supportive care |
| Enrollment | 30 (Estimated) |
| Sponsor | Tulane University (Other); collaborators: National Institute on Drug Abuse (NIDA) |
| Conditions | HIV, Substance Use (Drugs, Alcohol) |
| Interventions | TRIPP (Behavioral) |
| Dates | start 2026-12-01 (estimated), primary completion 2027-12-01 (estimated), completion 2027-12-01 (estimated), first posted 2025-07-28, last updated 2026-10-13 |
Related Papers Related Patents Related Grants Related Experts
All trials for HIV All trials for Substance Use (Drugs, Alcohol) All trials of TRIPP
The goal of this clinical trial is to explore whether a virtual reality (VR) mindfulness app is acceptable, appropriate, and feasible for supporting people with HIV and substance use problems.
Participants will:
* Use a VR headset with a mindfulness app at home;
* Complete three online surveys over three months;
* Take part in an individual interview or focus group to share their experiences.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| VR mindfulness | Experimental | Behavioral: TRIPP | Participants in this arm will receive a virtual reality (VR) mindfulness intervention named TRIPP. TRIPP is a commercially available VR mindfulness app designed to promote relaxation, focus, and emotional well-being through immersive, guided experiences. The app combines visual and auditory stimulation, breathwork, meditation, and interactive elements to help users reduce stress and improve mood. |
Sex: All, ages: 18 Years to any
Inclusion Criteria: * Able to speak, read, and write in English * Aged 18 years or older * Diagnosed with HIV * Currently prescribed ART therapy * Reporting moderate to high risk related to alcohol, opioids, nicotine, cannabis, or stimulant use (score of 4 or higher on the Alcohol, Smoking, and Substance Involvement Screening Test - ASSIST). Participants may also use other substances, but the primary risk must fall within these categories, as these have the strongest research support for mindfulness-based interventions. * Having stable housing that allow using VR safely * Willing to provide contact information for at least one person whom the study team can reach if the participant becomes unreachable after repeated attempts Exclusion Criteria: * Living in institutionalized settings or unsheltered * Terminal illness with a life expectancy of less than 6 months * Planning to move out of the area in the next eight weeks * Engaging in regular mindfulness practice outside of TRIPP * Experiencing fear of closed spaces or unable to tolerate wearing a VR headset (verified during orientation session) * Having visual or auditory impairments or severe physical disabilities that hinder VR use, history of seizures, severe cognitive impairment, severe motion sickness, severe unmanaged psychiatric symptoms, or currently pregnant * Participants without home internet access will not be excluded and will be provided either funding for internet service or VR headsets preloaded with TRIPP sessions for offline use.
NIH grants: R21DA061682